Sunny Patel

Sunny Patel has a diverse work experience spanning various industries and roles. Sunny is currently serving as a Board Member, Co-Founder, and Chief Partnership Officer at Neural Technologies since March 2022. Prior to that, they worked as a Strategic Advisor and Board Member at SPR Advisory from January 2020. During their time at SPR Advisory, they played a crucial role in advising the development and implementation of the Moderna COVID-19 vaccine, along with providing guidance to other clients such as Pfizer, Takeda, Merck, and AstraZeneca.

Sunny Patel has also founded their own consulting firm called Amber Consulting in September 2019. At Amber Consulting, they served as the Founder until February 2023. Additionally, they held the position of Chief Financial Officer at Zccounting.com from July 2020 to September 2022.

Before starting their entrepreneurial ventures, Sunny gained experience in the finance and consulting sectors. Sunny worked as a Healthcare M&A Advisor at Kaufman Hall from March 2019 to November 2020. Prior to that, they were a part of the International M&A division within the Investment Banking Division at PwC from February 2018 to September 2019.

Sunny'searlier experiences include working as an Investment Banking Associate at Bank of America from June 2015 to February 2018, a Business Valuation Associate at RSM US LLP from October 2015 to April 2016, and a Management Consultant at Verizon from June 2014 to August 2015. Sunny started their professional career as an Associate at Spencer Stuart from September 2014 to June 2015.

Sunny Patel has a background in finance and accounting. They pursued their education at DePaul University, where they focused on Finance Honors and Accounting. No specific start or end year is provided for their time at DePaul University.

In addition to their academic education, Sunny Patel also holds several certifications. They obtained the "Blockchain Certified Expert" certification from the Blockchain Council in July 2021. They also obtained certifications from FINRA, including the "Series 62: Corporate Securities Limited Representation," "Series 63: USA State Law," and "Series 79: Investment Banking Representative Exam" in March 2018. Furthermore, they obtained the "Bloomberg Fixed Income & Equities" certification from Bloomberg LP in November 2015.